Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"PTK6"”.

  1. Roles of EEF1A2 & PTK6 in breast cancer

    … gene expression. Phosphate Tyrosine Kinase-6 (PTK6) is also located on 20q13.3. It is 48kb upstream of EEF1A2. PTK6 is a non-receptor tyrosine-kinase that is normally expressed in epithelial linings, prostate, skin and oral epithelium but it is not detected in the normal human mammary …

    edinburgh Repository record for Roles of EEF1A2 & PTK6 in breast cancer (opens in a new tab)

  2. Modeling Brk/PTK6 expression in the mammary epithelium.

    … for new therapies. Breast tumor kinase (Brk/PTK6) is a non-receptor tyrosine kinase initially cloned from a metastatic breast tumor, and is overexpressed in ~86% of human breast tumors and several breast cancer cell lines. While expressed in differentiating cells in the skin and intestine, …

    umn Repository record for Modeling Brk/PTK6 expression in the mammary epithelium. (opens in a new tab)

  3. EXPLOITING DNA DAMAGE RESPONSE PATHWAY: DEVELOPMENT OF PTK6 INHIBITOR FOR TREATMENT OF OVARIAN CANCER

    … Through our preliminary investigations, we find PTK6 to be a modulator of ovarian carcinoma cell proliferation, cell death, migration, and invasion. Interestingly, evaluations through immunofluorescence of gH2AX and comet assay finds that PTK6 depletion significantly increases DNA damage and …

    nus Repository record for EXPLOITING DNA DAMAGE RESPONSE PATHWAY: DEVELOPMENT OF PTK6 INHIBITOR FOR TREATMENT OF OVARIAN CANCER (opens in a new tab) Download file for EXPLOITING DNA DAMAGE RESPONSE PATHWAY: DEVELOPMENT OF PTK6 INHIBITOR FOR TREATMENT OF OVARIAN CANCER (opens in a new tab)

  4. Post-translationally Modified Glucocorticoid Receptors and Protein Tyrosine Kinase 6 Modulate Triple Negative Breast Cancer Phenotypes

    … GR is known to induce the expression of PTK6, a soluble protein tyrosine kinase important in mediating signaling in response to cellular stress. PTK6 is overexpressed in 86% of breast cancer patients, regardless of subtypes. Although GR is known to modulate PTK6 expression in TNBC, …

    umn Repository record for Post-translationally Modified Glucocorticoid Receptors and Protein Tyrosine Kinase 6 Modulate Triple Negative Breast Cancer Phenotypes (opens in a new tab)

  5. Regulation of breast tumor Kinase (Brk/PTK6) downstream of Met receptor signaling leads to breast cancer cell migration.

    … transformation. Breast tumor kinase (Brk/PTK6) is a non-receptor or "soluble" tyrosine kinase that was cloned from a human metastatic breast tumor and found to be overexpressed in a majority (86%) of human breast tumors and cell lines. While Brk is abundant in normal differentiating …

    umn Repository record for Regulation of breast tumor Kinase (Brk/PTK6) downstream of Met receptor signaling leads to breast cancer cell migration. (opens in a new tab)

  6. Integration of physiologic (HIF) and hormone (GR) stress signaling pathways in the regulation of breast tumor kinase (Brk/PTK6) expression in triple-negative breast cancer.

    Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by breast tumor kinase, Brk, a driver of breast cancer cell migration and survival. Triple negative (basal type) breast cancers (TNBC) are aggressive …

    umn Repository record for Integration of physiologic (HIF) and hormone (GR) stress signaling pathways in the regulation of breast tumor kinase (Brk/PTK6) expression in triple-negative breast cancer. (opens in a new tab)

  7. The Genomic Evolution Of Breast Cancer Metastasis

    … loss of STK11 and CDKN2A/B, as well as gain of PTK6 and the membrane-bound progesterone receptor, PAQR8. PAQR8 gain was mutually exclusive with mutations in the nuclear estrogen and progesterone receptors, suggesting a role in treatment resistance. Several pathways were preferentially mutated or …

    penn Repository record for The Genomic Evolution Of Breast Cancer Metastasis (opens in a new tab)

  8. The role and mechanism of action of BRK in breast cancer progression

    … (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase that is highly expressed in over 80% of breast carcinomas. The role and mechanism of action of enzymatically activated BRK in breast pathology are unclear. The objectives of this project were to reveal the …

    sask Repository record for The role and mechanism of action of BRK in breast cancer progression (opens in a new tab)

  9. The Role of BRK in Gastric Cancer

    In 2020, gastric cancer proved to be an important health issue by not only being the 6th most diagnosed cancer, but also the 3rd most common cause of cancer-related deaths, after lung and liver cancer. Helicobacter pylori (H. pylori) is the main risk factor for gastric cancer incidences as it …

    sask Repository record for The Role of BRK in Gastric Cancer (opens in a new tab)

  10. Phosphoproteomics Analyses to Identify the Candidate Substrates and Signaling Intermediates of the Non-Receptor Tyrosine Kinase, SRMS

    SRMS (Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylaton sites) is a non-receptor tyrosine kinase that belongs to the BRK family kinases (BFKs) and is evolutionarily related to the Src family kinases (SFKs). Like SFKs and BFKs, the SRMS protein comprises of two …

    sask Repository record for Phosphoproteomics Analyses to Identify the Candidate Substrates and Signaling Intermediates of the Non-Receptor Tyrosine Kinase, SRMS (opens in a new tab)